- Survey data is consistently positive: microdosers report lower anxiety scores at 4 to 6 weeks. The catch: most studies are open-label and confounded by expectancy.
- The Maastricht placebo-controlled LSD microdose trial (Hutten 2024) found no significant anxiety reduction vs placebo in healthy adults.
- Microdosing helps some people with anxiety. It worsens it for others. Predicting which you are is hard before trying. Lower the dose, track outcomes.
- For full-dose protocols, end-of-life anxiety in cancer patients has the strongest single trial evidence (Griffiths 2016, Ross 2016).
- If you have GAD with prominent autonomic symptoms (racing heart, sweating, derealization), microdosing often amplifies them. Try non-psychedelic interventions first.
Anxiety, in plain terms
Generalized anxiety disorder (GAD) is persistent, excessive worry that is hard to control, accompanied by physical symptoms (muscle tension, fatigue, sleep disturbance, irritability). Around 3% of adults globally meet criteria. Social anxiety, panic disorder, specific phobias, and OCD-spectrum each have distinct profiles and treatment fits.
Standard care: SSRI/SNRI, CBT, sometimes benzodiazepines short-term. Around half achieve remission on first-line treatment. The rest are why we are talking.
How psilocybin and LSD act on anxiety circuits
Three plausible angles:
- 5-HT2A modulation in cortex. Reduces amygdala reactivity in some fMRI paradigms (Kraehenmann et al., 2015). Less threat-flagging.
- Default-mode network softening. The rumination engine quiets. People describe distance from anxious thoughts rather than the thoughts going away.
- Acute autonomic load. The flip side: psilocybin and LSD raise heart rate and blood pressure during the dose. For panic-prone or somatically anxious people, this can trigger the very state they are trying to escape.
Research summary
| Study | Year | Design | Finding |
|---|---|---|---|
| Griffiths et al., end-of-life cancer anxiety Note: this RCT measured anxiety in end-of-life cancer patients, not generalized anxiety disorder. The mechanism may not transfer cleanly to GAD. | 2016 | RCT, n=51, single high dose | ~80% sustained anxiety reduction at 6 months |
| Ross et al., NYU cancer anxiety | 2016 | RCT, n=29, single high dose | Significant anxiety reduction at 6.5 months |
| Polito & Stevenson, microdosing survey | 2019 | Open-label, n≈98 | Self-reported anxiety reduction at 6 weeks |
| Hutten et al., Maastricht LSD microdose | 2024 | Placebo-controlled, healthy adults | No significant mood/anxiety effect vs placebo |
| Szigeti et al., self-blinded RCT, eLife | 2021 | n=191, citizen-science RCT | Microdosing benefits matched placebo response |
Read this honestly: full-dose protocols have strong RCT evidence for end-of-life anxiety. Microdosing for general anxiety has surveys but no placebo-controlled win in healthy adults. The clinical anxiety microdose trial does not exist yet.
Observed protocols
Fadiman: Originally for LSD: 10-20 µg, day on, two days off, then day on again. Adapted to psilocybin: ~0.1 g dried at the same cadence for 4-8 weeks, then a 2-week pause. Fadiman himself noted this is a starting point for 1-2 months, not a fixed framework for everyone.- Stamets stack: 0.1 g psilocybin + lion’s mane + niacin, four days on, three days off.
Fadiman:
Stamets stack:For anxiety specifically, start lower than you think. 0.05 g psilocybin is a reasonable starting point. Anxiety-prone systems are more reactive to dose. Track HRV, sleep, and a daily 1-10 anxiety score.
Do not microdose if you have any of:
Active panic disorder with frequent attacks · Bipolar I or first-degree family history · Personal or family history of schizophrenia spectrum · Currently taking lithium, MAOIs · Pregnancy · Severe cardiovascular disease · Current SSRI without supervised plan · A history of psychosis under any substance.
The anxiety backfire pattern
The most common adverse pattern in our coaching cohort: high-baseline anxiety microdoser starts at typical dose, feels heightened heart rate or “buzzy” body, interprets as panic, escalates anxiety, blames the substance. The fix is almost always lower dose, slower start, breathwork stack.
- Somatic over-arousal. If your anxiety is body-first (heart, breath, derealization), microdosing’s acute autonomic effect can amplify it.
- Existential rumination. Some users find their anxious thoughts get bigger with reduced DMN filtering. Especially for OCD-spectrum.
- Sleep disruption. Late-day dosing reduces sleep depth in some users. Anxiety worsens with poor sleep. Compounding effect.
Who should not pursue this
- Anyone with active panic disorder.
- Anyone whose anxiety is currently disabling (work, sleep, relationships severely impacted) and unmanaged. Stabilize with standard care first.
- Anyone with OCD-spectrum where intrusive thoughts dominate.
- Anyone unable to track outcomes objectively across 4 to 6 weeks.
Integration practices (Micro-Movement Method, anxiety-specific)
Integration for anxiety is about teaching the nervous system safety through the body, not adding more cognitive load. The Micro-Movement Method approaches this through three anchors: breath, slow movement, and interoceptive contact. The differentiator is that every practice below downregulates sympathetic arousal rather than inadvertently stoking it.
- Cyclic sighing, twice dailyDouble inhale through the nose, long slow exhale through the mouth, 5 minutes morning and evening. Balban et al. (2023, Cell Reports Medicine) found cyclic sighing produced larger reductions in anxiety and improvements in mood than mindfulness meditation or box breathing. Pair with a low-dose day for a measurable stack.
- Grounded standing and slow walkingBarefoot if possible. Feel the soles, the knee tracking, the breath landing in the lower belly. Avoid running and high-intensity intervals during the integration window: in anxious systems, raising heart rate without an anchor often pulls toward panic rather than away from it.
- Polyvagal-informed body scan10 minutes, lying down, naming sensations without changing them. Areas that feel neutral or pleasant are deliberately revisited. This trains the vagal brake (Porges) rather than the threat-detection loop.
- Slow Soma yoga, not vinyasaFloor-based, low-arousal sequences. The Micro-Movement Method emphasizes micro-corrections inside small ranges of motion, which builds interoceptive accuracy without spiking activation. See our Soma yoga page.
- Avoid stimulating breathworkWim Hof, holotropic, and kapalabhati push toward hypocapnia and adrenergic arousal. In anxious systems these can trigger the very state the protocol is trying to soften. Reserve for stable baselines.
- Track HRV, not moodSubjective anxiety is noisy. Resting HRV trend over 4 weeks is the cleaner signal that the somatic stack is working.
When to seek professional help
If anxiety is interfering with work, sleep, or relationships and you are not in treatment, see a clinician. CBT and SSRIs are evidence-based first-line. They are usually tried before microdosing for good reason. For crisis: 988 (US), findahelpline.com.
